Table 1.
Origin of Extraction | Mechanism | Cell or Animal Model | Inducer | Mode of Action and Target Signal | Site of Action (Figure 1) | Ref. |
---|---|---|---|---|---|---|
Duzhong Fang | Inflammation | C57bl/6 mice | MPTP | ↓ locomotor dysfunction, inflammation, Iba1, microglia reactivity state ↑ striatal dopamine content, dopaminergic neurons, TH |
3 | [128] |
KOK | Inflammation | C57BL/6 mice | MPTP ML385 | ↓ neurological dysfunction and motor impairments, the loss of dopaminergic neurons and fibers, Iba1, the upregulation of inflammatory mediators (IL-6, TNF-α, COX-2, and iNOS), neurotoxicity (microglial activation and inflammatory response ↓), BBB disruption markers (PECAM-1 and GFAP), neurotoxicity and inflammation (phosphorylated forms of ERK, JNK, and p38 & IκB and NF-κB ↓), ROS, MAPKs and NF-κB signaling pathways ↑ Nrf2 signaling (decreases the expression levels of Keap1 (a repressor protein that binds to Nrf2), and increases the expression levels of Nrf2 transcription factor, Nrf2 targeting genes HO-1 and NQO-1) |
3 | [130] |
DBYW | Mitochondrial dysfunction | Rat PC-12 cells | pDJ-1 transfection MPP+ |
↓ DJ-1, mitochondrial dysfunction ↑ mitochondrial mass, total ATP content, the Akt phosphorylation |
2 | [132] |
BvPLA2 | Inflammation | Human A53T α-Syn Transgenic mice | A53T Transgenes | ↓ motor dysfunction, α-Syn, the activation and numbers of microglia, and the ratio of M1/M2 | 3 | [135] |
Hesperetin | Inflammation | Wistar rats | 6-OHDA | ↓ astrogliosis (GFAP ↓), apoptosis (nigral DNA fragmentation ↓), the loss of SNC dopaminergic neurons ↑ striatal catalase activity and GSH content, Bcl2 |
3 | [136] |
Paeonol | Inflammation | C57BL/6 mice | MPTP | ↓ motor dysfunction, oxidative stress (the activity levels of SOD, CAT, and GSH ↑), neuroinflammation(the number of Iba1-positive and IL-1β-positive cells ↓), ↑ TH-positive neurons, BDNF, dopaminergic neurons protection |
3 | [138] |
Gastrodin | Mitochondrial dysfunction | Drosophila melanogaster | PINK1 gene mutant | ↓ the loss of dopaminergic neurons, the onset of Parkinson-like phenotypes ↑ lifespan, climbing ability, resistance to oxidative stress, enzyme activities of superoxide dismutase (SOD) and catalase (CAT), the expression of anti-oxidative genes |
2 | [140] |
Trehalose | Lysosomal Disorders | Human A53T α-Syn Transgenic mice | A53T Transgenes | ↓ α-Synuclein-Induced Behavioral Impairment, α-Synuclein Accumulation ↑ DA Neuronal Survival, protection against the reduction of TH protein expression, autophagosome formation, LC3-II levels |
1 | [143] |
BSJDF | Lysosomal Disorders | Pheochromocytoma12 (PC12) | MPP+ (MPTP) |
improved cell survival in the PC12 cell PD model activated the autophagic process in PC12 cells. increased expression of Atg12 and LC3 proteins and upregulated Atg12 mRNA. |
1 | [146] |
NRD | inflammation | Wistar rats |
Rotenone | ↑ level of superoxide dismutase, catalase, and glutathione ↓ level of malondialdehyde inhibited the release of proinflammatory cytokines and inflammatory mediators prevented ROT-induced glial cell activation and the loss of dopaminergic neurons and nerve fibers attenuated rotenone-induced dopaminergic neurodegeneration. |
3 | [148] |
Vanillic acid | Mitochondrial dysfunction | Sprague Dawley rats | Rotenone | ↓ Weight gain, Catalepsy, Rearing TBARS level (at 25 mg/kg and 50 mg/kg) SAG(superoxide anion generation) ↑ behaviour, CAT |
2 | [149] |
Vanillin | Inflammation | Male Wistar rats | 6-OHDA | ↓ apomorphine-induced rotations, free radical release, expression of pro-inflammatory cytokines, lipid peroxidation ↑ striatal dopamine content, glutathione and superoxide dismutase enzyme protection of dopaminergic neurons |
3 | [151] |